Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder.

Steel C. et al, (2023), Int J Bipolar Disord, 11

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.

Goodwin GM. et al, (2023), Neuropsychopharmacology

Must Psilocybin Always "Assist Psychotherapy"?

Goodwin GM. et al, (2023), Am J Psychiatry

A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression.

Jauhar S. et al, (2023), Mol Psychiatry

Psilocybin for Treatment-Resistant Depression. Reply.

Goodwin GM. et al, (2023), N Engl J Med, 388

Unblinding and demand characteristics in the treatment of depression.

Goodwin GM. et al, (2023), J Affect Disord, 328, 1 - 5

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

Goodwin GM. et al, (2023), J Affect Disord

Identifying psychiatric diagnosis from missing mood data through the use of log-signature features

Wu Y. et al, (2022), PLOS ONE, 17, e0276821 - e0276821

Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.

Joas E. et al, (2022), Pharmacogenomics J

Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis.

Simon J. et al, (2022), Eur Neuropsychopharmacol, 66, 14 - 27

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

Goodwin GM. et al, (2022), N Engl J Med, 387, 1637 - 1648

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.

Similon MVM. et al, (2022), Eur Neuropsychopharmacol, 60, 91 - 99

Using a Generative Model of Affect to Characterize Affective Variability and its Response to Treatment in Bipolar Disorder

PULCU E. et al, (2022), Proceedings of the National Academy of Sciences of USA

Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.

Thomas CW. et al, (2022), Transl Psychiatry, 12

The costs of bipolar disorder in the United Kingdom.

Simon J. et al, (2021), Brain Behav

Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches.

Goodwin GM. and Stein DJ., (2021), Adv Ther

Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder.

Goodwin GM., (2021), Adv Ther

Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting.

Christensen MC. et al, (2021), J Affect Disord, 294, 924 - 931

Do environmental risk factors for the development of psychosis distribute differently across dimensionally assessed psychotic experiences?

Cosgrave J. et al, (2021), Transl Psychiatry, 11

Regional lithium prescription rates and recurrence in bipolar disorder

Goodwin GM., (2021), International Journal of Bipolar Disorders

Load More

1
2
3
4
5
6
7
...
»